| Phase 31 trial |
|
Phase 3
|
NCT05336786 |
Jun 2022 → May 2025 overdue |
prostate carcinoma |
Thomas Jefferson University |
Active not recruiting
|
No outcome recorded
|
| Phase not applicable4 trials |
| — |
NCT06797193 |
Mar 2025 → Mar 2027 expected |
portal hypertension |
Mayo Clinic |
Recruiting
|
No outcome recorded
|
| — |
NCT03300401 |
Nov 2017 → Nov 2019 |
hepatocellular carcinoma |
University of Southern California |
Withdrawn
|
No outcome recorded
Stop: Enrollment |
| — |
NCT00584402 |
Apr 2007 → Mar 2009 |
liver and intrahepatic bile duct neoplasm |
University of California, Davis |
Completed
|
No outcome recorded
|
| — |
NCT00631553 |
Jun 2006 → Dec 2009 |
kidney disorder |
University of Virginia |
Unknown
|
No outcome recorded
|
| Comparator or background therapy4 trials |
|
Phase 0
|
NCT03297112 Background |
Aug 2017 → Sep 2018 |
reproductive system neoplasm |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT06171607 Background |
Nov 2020 → Nov 2026 expected |
breast carcinoma |
University of Southern California |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT03045497 Background |
Dec 2012 → Dec 2013 |
hepatocellular carcinoma |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
Completed
|
No outcome recorded
|
|
Phase 2/3
|
NCT04715958 Background |
Dec 2020 → Oct 2026 expected |
breast carcinoma |
Kibo Nam |
Active not recruiting
|
No outcome recorded
|